PI3K Pathways Summit 2021
Evvnt Promotion / evvnt
Archivio
24.08.2021 - 26.08.2021 Online
Time: 9:00 am - 5:00 pm
Temi della conferenza
With 5 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years.
With 5 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/783356-3?pid=4832
Speakers: Zoe Johnson, Chief Scientific Officer, iOnctura, James Garner, Chief Executive Officer and Managing Director, Kazia Therapeutics and more
Brochure: https://go.evvnt.com/783356-3?pid=4832
Speakers: Zoe Johnson, Chief Scientific Officer, iOnctura, James Garner, Chief Executive Officer and Managing Director, Kazia Therapeutics and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/783356-0?pid=4832
Ms. Anita Kelemen
Medicina General, Oncologia
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
